Psychotic disorders in patients with epilepsy

Epilepsy is a chronic neurological disorder characterized by a persistent predisposition to generate recurrent epileptic seizures and the associated biological, cognitive, psychological, and social consequences. Psychiatric disorders are common among people with epilepsy and may arise from shared neurobiological mechanisms, the effects of recurrent seizures, psychosocial stressors, or adverse effects of antiepileptic medications.

Psychotic disorders are among the most serious psychiatric complications associated with epilepsy. They may occur in relation to seizure activity (postictal psychosis), between seizures (interictal psychosis), or rarely as a consequence of treatment-related factors. Prompt recognition and appropriate management are essential to improve patient outcomes and quality of life.

Epidemiology

Psychotic disorders occur more frequently in individuals with epilepsy than in the general population. The risk is particularly increased among patients with chronic epilepsy, temporal lobe epilepsy, poorly controlled seizures, and those with a long duration of illness.

Interictal psychosis is the most common chronic psychotic disorder associated with epilepsy, while postictal psychosis is typically acute and self-limiting.

Risk Factors

Factors associated with psychosis in epilepsy include:

• Long-standing epilepsy

• Poor seizure control

• Temporal lobe epilepsy

• Frequent generalized seizures

• Structural brain abnormalities

• Family history of psychiatric illness

• Cognitive impairment

• Psychosocial stressors

• Adverse effects of antiepileptic drugs

Pathophysiology

The exact mechanism underlying psychosis in epilepsy is not fully understood. Proposed mechanisms include:

• Dysfunction of limbic and temporal lobe structures

• Altered neurotransmitter activity involving dopamine, serotonin, and gamma-aminobutyric acid (GABA)

• Structural and functional brain abnormalities

• Neurobiological changes associated with recurrent seizures

• Psychiatric effects of certain antiepileptic medications

Psychotic symptoms may be directly related to seizure activity or may develop independently as a chronic psychiatric complication.

Clinical Presentation

Psychosis in epilepsy may present as postictal psychosis or interictal psychosis.

Symptoms

• Delusions

• Hallucinations

• Suspiciousness and paranoia

• Disorganized thinking

• Agitation

• Behavioral disturbances

• Emotional instability

• Social withdrawal

• Sleep disturbances

Clinical Signs

• Abnormal thought content

• Hallucinatory behavior

• Impaired judgment

• Poor insight

• Disorganized speech

• Altered affect

• Psychomotor agitation

Diagnostic Criteria

Diagnosis is based on:

• Established diagnosis of epilepsy

• Presence of psychotic symptoms

• Temporal relationship between psychosis and seizure activity

• Exclusion of substance-induced psychosis

• Exclusion of metabolic, infectious, or structural causes of altered mental status

• Comprehensive psychiatric assessment

Investigations

Laboratory Investigations

• Full blood count

• Blood glucose

• Renal function tests

• Liver function tests

• Electrolytes

• Toxicology screening where indicated

Neurological Investigations

• Electroencephalography (EEG)

• Brain CT scan or MRI where indicated

• Review of antiepileptic drug therapy

Psychiatric Assessment

• Mental status examination

• Risk assessment for aggression and self-harm

• Assessment of psychosocial functioning

Management

Management aims to achieve seizure control, reduce psychotic symptoms, improve functioning, and prevent relapse.

Non-Pharmacological Treatment

• Psychoeducation to the patient and family

• Family therapy

• Supportive group therapy

• Occupational therapy

• Psychosocial rehabilitation

• Adherence counselling

• Regular psychiatric and neurological follow-up

Pharmacological Treatment

Optimize antiepileptic therapy using one of the following:

• Carbamazepine (PO) 200–1000 mg per day in divided doses. Symptoms should be monitored and medication titrated accordingly.

OR

• Phenobarbitone (PO) 30–200 mg per day in divided doses. Symptoms should be monitored and medication titrated accordingly.

OR

• Sodium valproate (PO) 500–2000 mg per day in divided doses. Symptoms should be monitored and medication titrated accordingly.

If psychosis persists, add one of the following antipsychotic medications:

• Haloperidol (PO) 0.75–4.5 mg every 12 hours. Maximum dose 20 mg/day.

OR

• Olanzapine (PO) 5–10 mg per day in divided doses. Maximum dose 20 mg/day. Symptoms should be monitored and medication titrated accordingly.

OR

• Risperidone (PO) 0.5 mg every 12 hours, then increase by 1 mg every 2–3 days to 2–3 mg every 12 hours. Maximum dose 16 mg/day.

Management according to underlying cause

Postictal Psychosis

• Optimize seizure control

• Close observation and supportive care

• Short-term antipsychotic therapy when required

• Monitor for spontaneous resolution

Interictal Psychosis

• Long-term psychiatric follow-up

• Antipsychotic treatment when indicated

• Continued optimization of antiepileptic therapy

Referral

Refer the patient when:

• Diagnosis is uncertain

• Psychosis is severe or recurrent

• There is risk of violence or self-harm

• Seizures remain poorly controlled

• Specialized psychiatric care is required

• Hospital admission is necessary

Complications

• Medication non-adherence

• Increased seizure frequency

• Social dysfunction

• Occupational impairment

• Family disruption

• Aggressive behavior

• Hospitalization

• Reduced quality of life

Prognosis

The prognosis depends on seizure control, underlying neurological pathology, treatment adherence, and timely psychiatric intervention. Postictal psychosis generally has a favorable prognosis and often resolves spontaneously, whereas interictal psychosis may require long-term treatment and follow-up.

Prevention

• Early diagnosis and treatment of epilepsy

• Optimal seizure control

• Adherence to antiepileptic medication

• Early recognition of psychiatric symptoms

• Regular neurological and psychiatric review

• Avoidance of medications that lower the seizure threshold

• Patient and family education

Special considerations

• Postictal psychosis may remit spontaneously even without treatment, although effective antipsychotic therapy may shorten symptom duration.

• Interictal psychosis is treated with antipsychotic medication.

• Medications that lower the seizure threshold should be avoided.

• Atypical antipsychotics may have more favorable safety profiles than typical antipsychotics.

• Antipsychotic doses should be kept as low as clinically effective.